Mechanisms and Inhibitors

Basic Catalytic Strategies of Enzymes

• Transition-State Formation and Catalysis:

  • Enzymes catalyze diverse biochemical reactions by accelerating reaction rates through the stabilization and facilitation of transition-state formation.

  • While the specific molecular pathways differ among individual enzymes, the fundamental driving force of enzymatic catalysis is the maximal binding energy established when the enzyme selectively engages the transition state rather than the substrate in its ground state.

  • Enzymes commonly use one or a combination of four distinct catalytic strategies to achieve transition-state lowering:

  • Covalent catalysis.

  • General acid–base catalysis.

  • Metal ion catalysis.

  • Catalysis by approximation.

• Covalent Catalysis:

  • In covalent catalysis, the active site of the enzyme possesses a highly reactive chemical group that becomes temporarily modified through a covalent bond with the substrate during the catalytic cycle.

  • The reactive group is typically a powerful nucleophile.

  • Nucleophile Definition: An electron-rich atom or chemical group possessing unshared electron pairs that is attracted to regions of positive charge or electron deficiency in other molecules. Nucleophiles participate in chemical reactions by donating electron pairs to electrophiles.

  • Electrophile Definition: An electron-deficient chemical group or atom that is attracted to electron-rich or negatively charged centers. Electrophiles participate in reactions by accepting electron pairs from nucleophiles.

• General Acid–Base Catalysis:

  • In general acid–base catalysis, a chemical species other than a hydronium ion ($\text{H}_3\text{O}^+$) or hydroxide ion ($\text{OH}^-$) functions as a proton donor or proton acceptor.

  • Enzyme active sites utilize ionizable amino acid side chains to mediate proton transfers, which prevents reliance solely on ambient water molecules.

  • Example: Chymotrypsin utilizes the imidazole ring of a histidine residue ($\text{His 57}$) as a base catalyst to abstract a proton from a serine residue ($\text{Ser 195}$), significantly augmenting the nucleophilic reactivity of the serine oxygen.

• Metal Ion Catalysis:

  • Bound metal ions can participate in catalytic mechanisms through several distinct pathways:

  • Electrophilic Catalysis: Positively charged metal ions stabilize negative charges that accumulate on reaction intermediates or transition states.

  • Nucleophile Generation: A metal ion can polarize an adjacent bound molecule (such as water), lowering its $\text{p}K_a$ and generating a reactive nucleophile (such as an active hydroxide ion) at neutral $\text{pH}$.

  • Substrate Binding and Orientation: A metal ion can form coordinate bonds directly with the substrate, increasing the total number of noncovalent interactions between enzyme and substrate, thereby providing essential binding energy.

  • Cofactor Function: Metal ions serve as obligatory cofactors for numerous metabolic enzymes.

• Catalysis by Approximation and Orientation:

  • Biochemical reactions involving two or more distinct substrates often encounter significant entropic barriers to product formation.

  • Catalysis by approximation considerably enhances the reaction rate by binding multiple substrates along a common active-site surface, bringing them into close proximity and aligning their reactive groups in the precise spatial orientation required for reaction.

• Binding Energy in Catalytic Promotion:

  • The full complement of noncovalent interactions (hydrogen bonds, electrostatic interactions, and van der Waals forces) between an enzyme and its substrate forms exclusively when the substrate reaches the transition-state geometry.

  • Maximal binding energy is released upon transition-state binding, which thermodynamically offsets the activation energy barrier ($\Delta G^\ddagger$) and accelerates the catalytic conversion of substrate to product.

Environmental Modulation of Enzyme Activity: Temperature and pH

• Temperature Effects on Enzymatic Catalysis:

  • Increasing temperature increases the kinetic energy and Brownian motion of reactant molecules, thereby elevating collision frequencies between an enzyme and its substrate and enhancing the reaction velocity.

  • For most enzymes, catalytic activity rises steadily with temperature until an optimum is reached; beyond this temperature, catalytic activity declines precipitously.

  • This loss of activity occurs because the weak noncovalent interactions (hydrogen bonds, ionic interactions, hydrophobic effects) stabilizing the precise native three-dimensional conformation of the protein cannot withstand the disruptive thermal agitation, resulting in protein denaturation.

• Thermal Adaptations in Endotherms and Ectotherms:

  • Endotherms: Organisms (including humans) that maintain a constant internal core body temperature insulate their enzymatic systems from environmental temperature fluctuations. Localized increases in tissue temperature, such as those generated by muscular exertion during physical warm-up, slightly enhance enzymatic turnover rates that sustain muscular work.

  • Ectotherms: Organisms whose body temperatures fluctuate with ambient conditions depend on environmental temperature to drive their internal biochemical machinery. For instance, lizards exhibit high physiological activity in warm environments and enter states of lethargy in cooler temperatures.

  • Thermophiles: Specialized organisms, such as thermophilic archaea inhabiting geothermal vents or hot springs, thrive at temperatures of $80\,^\circ\text{C}$ or greater. Their enzymes possess structural evolutionary adaptations—such as elevated core hydrophobicity, extensive salt bridges, and compact packing—that confer resilience against thermal denaturation.

• pH Dependence and Optimal pH Profiles:

  • The velocity of enzyme-catalyzed reactions varies markedly with environmental hydrogen ion concentration ($[\text{H}^+]$).

  • Most enzymes display a characteristic bell-shaped activity curve when plotted against $\text{pH}$.

  • The optimum $\text{pH}$ at which an enzyme functions at maximal velocity corresponds to the physiological environment in which that enzyme operates:

  • Pepsin: A proteolytic enzyme operating in the acidic milieu of the stomach displays an optimum between $\text{pH } 1$ and $\text{pH } 2$.

  • Chymotrypsin: A pancreatic digestive enzyme secreted into the upper small intestine operates optimally near $\text{pH } 8$.

• Molecular Basis of pH Sensitivity: Ionizable R Groups:

  • The $\text{pH}$ dependence of enzymatic activity is dictated by the ionization state of critical amino acid side chains within the active site or structural framework of the protein.

  • A typical bell-shaped curve often reflects the requirement for two specific ionizable side-chain states simultaneously:

  • Consider an enzyme requiring an unprotonated carboxylate group (e.g., from a glutamic acid residue, $-\text{COO}^-$) acting as a base, and a protonated amino group (e.g., from a lysine residue, $-\text{NH}_3^+$) acting as an acid:

    • As environmental $\text{pH}$ drops below the optimum, the carboxylate group accepts a proton, shifting the equilibrium $-\text{COO}^- + \text{H}^+ \rightleftharpoons -\text{COOH}$. Neutralization of this residue abolishes its catalytic function, decreasing enzyme velocity.

    • As environmental $\text{pH}$ rises above the optimum, the ammonium group deprotonates, shifting the equilibrium $-\text{NH}_3^+ + \text{OH}^- \rightleftharpoons -\text{NH}_2 + \text{H}_2\text{O}$. Deprotonation converts it to a neutral amine, eliminating catalytic capacity and causing activity to decline.

Reversible Enzyme Inhibition: Mechanisms and Kinetics

• Overview of Enzyme Inhibition:

  • Specific small molecules and ions can bind to enzymes to attenuate their catalytic activity.

  • Inhibition serves as a primary endogenous regulatory mechanism in cellular metabolism, particularly for modulating allosteric enzymes.

  • Synthetic and natural inhibitors serve as critical pharmacological agents, investigative tools to determine catalytic mechanisms, and probes to identify essential active-site residues.

  • Enzyme inhibition is classified broadly as either reversible or irreversible.

• Classification of Reversible Inhibition:

  • Reversible inhibition involves rapid noncovalent interactions between an inhibitor and an enzyme, characterized by a measurable dissociation equilibrium for the enzyme–inhibitor complex.

  • Three primary categories of reversible inhibition are recognized:

  • Competitive inhibition.

  • Uncompetitive inhibition.

  • Noncompetitive inhibition (pure and mixed).

• Competitive Inhibition:

  • Mechanism: The competitive inhibitor ($I$) shares structural homology with the natural substrate ($S$) and competes directly with it for access to the free enzyme's active site ($E$). The enzyme can bind the substrate ($ES$) or the inhibitor ($EI$), but cannot bind both simultaneously ($ESI$ does not form):   $E + S \rightleftharpoons ES \rightarrow E + P$   $E + I \rightleftharpoons EI$

  • Kinetic Consequences:

  • Competitive inhibition reduces the proportion of active enzyme molecules bound to substrate at any given substrate concentration.

  • Because the inhibitor binds reversibly at the catalytic locus, high concentrations of substrate displace the inhibitor via mass action. Consequently, the maximal velocity ($V_{\max}$) of the reaction is unchanged.

  • A higher concentration of substrate is required to achieve half-maximal velocity; thus, the apparent Michaelis constant ($K_M^{\text{app}}$) is increased:     $K_M^{\text{app}} = K_M \left(1 + \frac{[I]}{K_i}\right)$

  • Lineweaver–Burk Characteristics:

  • The double-reciprocal plot ($1/V_0$ versus $1/[S]$) displays lines that intersect directly on the vertical $y$-axis at $1/V_{\max}$.

  • The slope of the line, represented by $K_M^{\text{app}} / V_{\max}$, increases in the presence of inhibitor.

  • The horizontal $x$-intercept ($-1/K_M^{\text{app}}$) shifts closer toward the origin ($0$).

• Uncompetitive Inhibition:

  • Mechanism: The uncompetitive inhibitor binds exclusively to the enzyme–substrate complex ($ES$), rather than to the free enzyme ($E$). The inhibitor binding site is an allosteric pocket that is created through conformational changes induced upon substrate binding:   $E + S \rightleftharpoons ES \rightarrow E + P$   $ES + I \rightleftharpoons ESI$

  • Kinetic Consequences:

  • The resulting enzyme–substrate–inhibitor complex ($ESI$) is catalytically inactive and cannot proceed to yield product.

  • Uncompetitive inhibition cannot be reversed by increasing the concentration of substrate because substrate binding promotes inhibitor binding.

  • The catalytic capacity of active enzyme complexes is reduced, which decreases the apparent maximal velocity ($V_{\max}^{\text{app}}$).

  • Because the binding of inhibitor depletes $ES$ complexes via Le Chatelier's principle, the equilibrium shifts to pull more free enzyme ($E$) into the $ES$ state, which increases apparent substrate affinity and lowers the apparent Michaelis constant ($K_M^{\text{app}}$) by the exact same factor as $V_{\max}$:     $V_{\max}^{\text{app}} = \frac{V_{\max}}{1 + \frac{[I]}{K_i'}}$     $K_M^{\text{app}} = \frac{K_M}{1 + \frac{[I]}{K_i'}}$

  • Lineweaver–Burk Characteristics:

  • The slope of the line ($K_M / V_{\max}$) remains constant because $K_M$ and $V_{\max}$ decrease by the identical ratio.

  • The inhibited lines run completely parallel to the uninhibited line.

  • The vertical $y$-intercept ($1/V_{\max}^{\text{app}}$) increases.

  • The horizontal $x$-intercept ($-1/K_M^{\text{app}}$) moves further to the left, away from the origin.

• Noncompetitive Inhibition (Pure and Mixed):

  • Mechanism: A noncompetitive inhibitor binds to an allosteric site structurally distinct from the catalytic active site. As a result, the inhibitor can bind simultaneously with the substrate to form an inactive quaternary complex:   $E + S \rightleftharpoons ES \rightarrow E + P$   $E + I \rightleftharpoons EI$   $ES + I \rightleftharpoons ESI$   $EI + S \rightleftharpoons ESI$

  • Pure Noncompetitive Inhibition:

  • In pure noncompetitive inhibition, the dissociation constant for binding the free enzyme ($K_i$) is identical to the dissociation constant for binding the enzyme–substrate complex ($K_i'$).

  • The inhibitor decreases the effective catalytic turnover number ($k_{\text{cat}}$) without perturbing the binding affinity of the substrate for the active site.

  • Kinetic Consequences: Maximal velocity is reduced ($V_{\max}^{\text{app}} < V_{\max}$), whereas the Michaelis constant remains unchanged ($K_M^{\text{app}} = K_M$).

  • Lineweaver–Burk Characteristics: The double-reciprocal plots intersect precisely on the horizontal $x$-axis at the point $-1/K_M$. The slope and vertical $y$-intercept ($1/V_{\max}^{\text{app}}$) increase by identical proportional factors.

  • Mixed Noncompetitive Inhibition:

  • The inhibitor displays differential affinity for the free enzyme versus the enzyme–substrate complex ($K_i \neq K_i'$).

  • Maximal velocity is consistently reduced ($V_{\max}^{\text{app}} < V_{\max}$).

  • If the inhibitor binds with higher affinity to free enzyme ($E$) than to $ES$ ($K_i < K_i'$), the apparent $K_M$ increases ($K_M^{\text{app}} > K_M$).

  • If the inhibitor binds preferentially to the enzyme–substrate complex ($ES$) over free enzyme ($K_i > K_i'$), the apparent $K_M$ decreases ($K_M^{\text{app}} < K_M$).

  • The double-reciprocal plots intersect at a point either above or below the horizontal $x$-axis to the left of the vertical $y$-axis.

• Quantitative Evaluation of Inhibition Type: Worked Experimental Analysis:

  • Experimental velocity measurements recorded in the absence and presence of an unknown inhibitor across varying substrate concentrations:

• Calculating double-reciprocal values for Lineweaver–Burk analysis ($1/[S]$ versus $1/V_0$):

• Linear Regression Parameters and Kinetic Calculations:

  • Uninhibited Enzyme Equation: $y = 0.224x + 0.0224$

    • Maximal Velocity ($V_{\max}$):       $V_{\max} = \frac{1}{\text{y-intercept}} = \frac{1}{0.0224} = 44.6\,\mu\text{mol/min}$

    • Michaelis Constant ($K_M$):       $K_M = \frac{\text{slope}}{\text{y-intercept}} = \frac{0.224}{0.0224} = 10.0\,\mu\text{M}$

  • Inhibited Enzyme Equation: $y = 1.1084x + 0.1125$

    • Apparent Maximal Velocity ($V_{\max}^{\text{app}}$):       $V_{\max}^{\text{app}} = \frac{1}{\text{y-intercept}} = \frac{1}{0.1125} = 8.89\,\mu\text{mol/min}$

    • Apparent Michaelis Constant ($K_M^{\text{app}}$):       $K_M^{\text{app}} = \frac{\text{slope}}{\text{y-intercept}} = \frac{1.1084}{0.1125} = 9.85\,\mu\text{M}$

• Diagnostic Conclusion:

  • The two linear regressions converge and intersect directly on the horizontal $x$-axis at approximately $-0.1\,\mu\text{M}^{-1}$ ($-1/K_M = -1/10.0\,\mu\text{M} = -0.10\,\mu\text{M}^{-1}$).

  • Because $K_M$ is virtually unchanged ($10.0\,\mu\text{M}$ vs. $9.85\,\mu\text{M}$) while $V_{\max}$ drops substantially from $44.6\,\mu\text{mol/min}$ to $8.89\,\mu\text{mol/min}$, this behavior demonstrates noncompetitive inhibition.

Irreversible Enzyme Inhibition and Transition-State Analogs

• Transition-State Analogs (TSAs):

  • In 1948, Linus Pauling postulated that because enzymes accelerate reactions by stabilizing the transition state, stable chemical compounds synthesized to mimic the transition state should bind to the active site with substantially greater affinity than the substrate itself.

  • Transition-state analogs act as exceptionally potent and selective competitive inhibitors.

  • The high affinity of these compounds provides evidence supporting proposed transition-state geometries and chemical reaction mechanisms.

  • TSA inhibition reinforces the concept that catalytic power stems from the selective, high-affinity binding of the transition-state structure relative to the ground-state substrate.

• Classes of Irreversible Inhibitors:

  • Irreversible inhibitors dissociate extremely slowly from target enzymes because they form covalent bonds or tight noncovalent complexes with active-site functional groups.

  • Irreversible inhibitors are classified into three mechanistic groups:

  • Group-specific reagents.

  • Affinity labels (reactive substrate analogs).

  • Mechanism-based (suicide) inhibitors.

• Group-Specific Reagents:

  • Chemical reagents that covalently modify particular amino acid side chains without selective active-site targeting.

  • Diisopropylphosphofluoridate (DIPF): A classic group-specific reagent that phosphorylates reactive serine hydroxyl groups.

  • DIPF irreversibly inactivates chymotrypsin by modifying only one unique serine ($\text{Ser 195}$) out of the 28 total serine residues present in the enzyme.

  • DIPF also covalently modifies an essential active-site serine residue in acetylcholinesterase, an enzyme required for degrading the neurotransmitter acetylcholine during nerve impulse transmission across cholinergic synapses.

• Affinity Labels (Reactive Substrate Analogs):

  • Molecules that structurally mimic the substrate, enabling them to bind specifically into the active-site cavity, where an attached reactive chemical moiety forms a covalent bond with an adjacent amino acid residue.

  • They exhibit greater active-site specificity than group-specific reagents.

  • Tosyl-L-phenylalanine chloromethyl ketone (TPCK):

  • Serves as an affinity label for chymotrypsin.

  • The phenylalanine moiety of TPCK binds into the hydrophobic substrate-binding pocket ($\text{S}_1$ pocket).

  • The adjacent reactive chloromethyl ketone electrophile reacts covalently with an imidazole ring nitrogen of $\text{His 57}$ at the active site, inactivating the enzyme.

• Mechanism-Based (Suicide) Inhibitors:

  • Chemically modified substrate analogs that are recognized and processed by the enzyme via its normal catalytic pathway.

  • During catalytic turnover, the enzyme converts the inhibitor into a chemically reactive intermediate that irreversibly modifies active-site residues, inactivating the enzyme.

  • Because the target enzyme catalytically generates the reactive group that inactivates it, suicide inhibitors provide direct proof that the modified residue is essential for catalysis.

• Clinical Application: Penicillin as a Suicide Inhibitor of Bacterial Cell-Wall Synthesis:

  • Penicillin, the first clinical antibiotic discovered, functions as an irreversible suicide inhibitor.

  • Chemical Structure: Penicillin consists of a thiazolidine ring fused to a strained four-membered $\beta$-lactam ring, linked to a variable acyl side-chain ($R$ group) via an amide bond.

• Physiological Target in Bacteria:

  • Bacterial cell walls (e.g., in Staphylococcus aureus) are composed of peptidoglycan, a macromolecular meshwork consisting of linear polysaccharide chains cross-linked by short oligopeptides.

  • The peptidoglycan layer provides structural integrity, preventing osmotic lysis from high internal turgor pressures.

  • The enzyme glycopeptide transpeptidase catalyzes the final transpeptidation reaction that cross-links adjacent peptide strands to stabilize the wall.

• Mechanism of Inactivation:

  • Penicillin acts as a structural analog of the terminal $\text{D-alanyl-D-alanine}$ ($\text{D-Ala-D-Ala}$) moiety of the normal transpeptidase peptide substrate.

  • When penicillin enters the transpeptidase active site, the active-site serine residue attacks the carbonyl carbon of the strained $\beta$-lactam ring.

  • Nucleophilic attack opens the four-membered ring and forms a stable, covalent penicilloyl-serine derivative (penicilloyl-enzyme complex).

  • Because the penicilloyl moiety does not deacylate, the enzyme is permanently locked in an inactive state, halting bacterial cell-wall assembly and causing cell death.

• Christopher T. Walsh and Enzymatic Reaction Mechanisms:

  • Christopher T. Walsh (1944–2023) advanced the chemical understanding of enzymatic reaction mechanisms, suicide inhibition, antibiotic action, antimicrobial resistance, and microbial natural-product biosynthesis.

  • Walsh began his faculty career in 1972 holding a joint appointment in biology and chemistry at the Massachusetts Institute of Technology, and later conducted research at Harvard Medical School and the Dana-Farber Cancer Institute.

  • During a research career spanning over four decades, Walsh authored three textbooks, published more than 800 peer-reviewed scientific papers, and trained over 250 graduate students and postdoctoral fellows, emphasizing gender equity in biochemical science.

Catalytic Mechanism and Specificity of Chymotrypsin

• Protein Turnover and Proteolytic Enzymes:

  • Protein turnover is essential for clearing damaged or obsolete proteins, recycling amino acids for synthesis, and digesting dietary proteins in the gastrointestinal tract for intestinal absorption.

  • Proteolytic degradation is catalyzed by proteases (proteolytic enzymes), which cleave internal peptide bonds via a hydrolysis reaction:   $\text{R}_1\text{-CO-NH-R}_2 + \text{H}_2\text{O} \rightleftharpoons \text{R}_1\text{-COO}^- + \text{R}_2\text{-NH}_3^+$

• Substrate Specificity of Chymotrypsin:

  • Chymotrypsin is a pancreatic serine protease that hydrolyzes peptide bonds on the carboxyl-terminal side of bulky hydrophobic or aromatic amino acids, including phenylalanine ($\text{Phe}$), tyrosine ($\text{Tyr}$), tryptophan ($\text{Trp}$), methionine ($\text{Met}$), and isoleucine ($\text{Ile}$).

• Pre-Steady-State Kinetics and Chromogenic Substrates:

  • Chymotrypsin activity can be monitored spectrophotometrically using the synthetic chromogenic substrate $N$-acetyl-L-phenylalanine $p$-nitrophenyl ester.

  • Chymotrypsin cleaves this ester to yield a yellow product, $p$-nitrophenolate, which absorbs light strongly at $400\text{--}410\,\text{nm}$.

• Stopped-flow kinetic analysis reveals a characteristic biphasic reaction profile:

  • Burst Phase: Rapid initial release of stoichiometric quantities of $p$-nitrophenolate within milliseconds of substrate mixing, equaling the molar concentration of active enzyme present.

  • Steady-State Phase: A transition to a slower, linear production of $p$-nitrophenolate that obeys classic Michaelis–Menten steady-state kinetics.

• Two-Step Mechanism: Acylation and Deacylation:

  • The biphasic burst-phase kinetics demonstrate that chymotrypsin catalysis proceeds in two successive chemical stages via a covalent intermediate:

  • Acylation (Step 1 - Rapid): The nucleophilic hydroxyl group of $\text{Ser 195}$ attacks the carbonyl group of the substrate, cleaving the ester or amide linkage. The acyl component of the substrate forms a covalent ester bond with the enzyme, generating an acyl-enzyme intermediate while rapidly liberating the first product ($p$-nitrophenolate or the amine component of a peptide).

  • Deacylation (Step 2 - Slow / Rate-Limiting): An incoming water molecule hydrolyzes the acyl-enzyme intermediate, releasing the carboxylic acid substrate product and regenerating the unmodified free serine hydroxyl to reset the catalytic cycle.

• The Catalytic Triad:

  • The active site of chymotrypsin contains three conserved amino acid residues that form a hydrogen-bonded catalytic network:

  • Aspartate 102 ($\text{Asp 102}$).

  • Histidine 57 ($\text{His 57}$).

  • Serine 195 ($\text{Ser 195}$).

  • Structural Organization and Functional Roles:

  • The side-chain hydroxyl group of $\text{Ser 195}$ forms a hydrogen bond with the unprotonated $\text{N}-3$ atom of the imidazole ring of $\text{His 57}$.

  • The protonated $\text{N}-1$ atom of the $\text{His 57}$ imidazole ring forms a hydrogen bond with the carboxylate group of $\text{Asp 102}$.

  • Histidine 57: Serves as a general base catalyst by abstracting the hydroxyl proton from $\text{Ser 195}$, converting the weak serine hydroxyl into a strongly nucleophilic alkoxide ion. In subsequent stages, protonated $\text{His 57}$ functions as a general acid catalyst by donating a proton to departing amine or serine groups.

  • Aspartate 102: Optimizes the orientation of the $\text{His 57}$ imidazole ring through electrostatic interactions and hydrogen bonding, increasing the basicity and proton-accepting capacity of the histidine.

• Comprehensive Eight-Step Mechanism of Peptide Hydrolysis:

  • Step 1: Substrate Binding: The polypeptide substrate binds noncovalently into the active site; the hydrophobic side chain preceding the scissile bond docks into the adjacent hydrophobic binding pocket ($\text{S}_1$ pocket), positioning the carbonyl carbon of the target peptide bond near $\text{Ser 195}$.

  • Step 2: Nucleophilic Attack and First Tetrahedral Intermediate Formation: $\text{His 57}$ acts as a general base, abstracting the proton from the $\text{Ser 195}$ hydroxyl group. The activated alkoxide oxygen attacks the electrophilic carbonyl carbon of the scissile peptide bond. This transforms the planar carbonyl group into an unstable tetrahedral intermediate bearing a formal negative charge on the carbonyl oxygen atom.

  • Step 3: Collapse of the Tetrahedral Intermediate: The oxyanion collapses back to reform the carbon–oxygen double bond ($\text{C}=\text{O}$). The peptide bond is cleaved, and the protonated $\text{His 57}$ acts as a general acid catalyst, donating its acquired proton to the leaving amine group ($\text{R}_2\text{-NH}_2$).

  • Step 4: Release of the Amine Component: The cleaved amine product diffuses away from the active site, leaving the substrate's acyl group covalently esterified to $\text{Ser 195}$ as the stable acyl-enzyme intermediate (completing the acylation phase).

  • Step 5: Water Binding: A water molecule from the solvent enters the active site and occupies the region vacated by the departing amine group.

  • Step 6: Nucleophilic Attack by Water: $\text{His 57}$ acts as a general base catalyst, abstracting a proton from the incoming water molecule. The resulting hydroxide ion attacks the carbonyl carbon of the acyl-enzyme intermediate, producing a second tetrahedral intermediate with an oxyanion on the carbonyl oxygen.

  • Step 7: Collapse of the Second Tetrahedral Intermediate: The second tetrahedral intermediate collapses, reforming the carbonyl double bond. $\text{His 57}$ acts as a general acid catalyst, transferring a proton back to the oxygen atom of $\text{Ser 195}$, which cleaves the covalent acyl-enzyme ester bond.

  • Step 8: Release of the Carboxylic Acid Product: The carboxylic acid product dissociates from the catalytic cleft, restoring the catalytic triad ($\text{Asp 102}$, $\text{His 57}$, $\text{Ser 195}$) to its initial uncharged state for subsequent catalytic cycles.

• Stabilization of the Transition State: The Oxyanion Hole:

  • The tetrahedral intermediates formed in Steps 2 and 6 place a full negative charge on the former carbonyl oxygen atom (an oxyanion).

  • This unstable negative charge is stabilized by a specialized active-site structural pocket termed the oxyanion hole.

  • The oxyanion is stabilized by hydrogen bonds donated from the peptide backbone amide ($-\text{NH}-$) groups of glycine 193 ($\text{Gly 193}$) and serine 195 ($\text{Ser 195}$).

  • These hydrogen-bonding interactions preferentially engage the transition state and tetrahedral intermediate rather than the ground-state planar peptide substrate, providing binding energy that lowers the overall activation barrier ($\Delta G^\ddagger$).

• Structural Basis of Specificity: The S1 Pocket:

  • The substrate specificity of chymotrypsin is dictated by a deep, nonpolar invagination adjacent to the active site known as the $\text{S}_1$ specificity pocket.

  • The $\text{S}_1$ pocket is lined with hydrophobic and uncharged amino acid residues, including $\text{Ser 189}$, $\text{Cys 191}$, $\text{Met 192}$, $\text{Trp 215}$, $\text{Gly 216}$, and $\text{Ser 217}$.

  • Bulky, nonpolar aromatic side chains (such as those of phenylalanine, tyrosine, or tryptophan) fit into this hydrophobic cleft.

  • Insertion of a recognized side chain into the $\text{S}_1$ pocket aligns the adjacent scissile peptide bond directly into the catalytic triad and oxyanion hole for cleavage.